115 related articles for article (PubMed ID: 9741997)
41. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
McCormick PN; Wilson VS; Wilson AA; Remington GJ
Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
[TBL] [Abstract][Full Text] [Related]
42. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Millan MJ; Svenningsson P; Ashby CR; Hill M; Egeland M; Dekeyne A; Brocco M; Di Cara B; Lejeune F; Thomasson N; Munoz C; Mocaër E; Crossman A; Cistarelli L; Girardon S; Iob L; Veiga S; Gobert A
J Pharmacol Exp Ther; 2008 Feb; 324(2):600-11. PubMed ID: 18024787
[TBL] [Abstract][Full Text] [Related]
43. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
Zhang M; Ballard ME; Unger LV; Haupt A; Gross G; Decker MW; Drescher KU; Rueter LE
Behav Brain Res; 2007 Aug; 182(1):1-11. PubMed ID: 17570538
[TBL] [Abstract][Full Text] [Related]
44. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.
Zapata A; Shippenberg TS
Neuropharmacology; 2005 Jan; 48(1):43-50. PubMed ID: 15617726
[TBL] [Abstract][Full Text] [Related]
45. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
[TBL] [Abstract][Full Text] [Related]
46. Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI.
Fink-Jensen A; Nielsen EB; Hansen L; Scheideler MA
Eur J Pharmacol; 1998 Jan; 342(2-3):153-61. PubMed ID: 9548380
[TBL] [Abstract][Full Text] [Related]
47. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
Skuza G; Rogóz Z; Wieczorek A
Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
[TBL] [Abstract][Full Text] [Related]
48. The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat.
Bristow LJ; Cook GP; Gay JC; Kulagowski JJ; Landon L; Murray F; Saywell KL; Young L; Hutson PH
Neuropharmacology; 1996 Mar; 35(3):285-94. PubMed ID: 8783203
[TBL] [Abstract][Full Text] [Related]
49. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
[TBL] [Abstract][Full Text] [Related]
50. Effects of selective activation of dopamine D2 and D3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons.
Durham RA; Eaton MJ; Moore KE; Lookingland KJ
Eur J Pharmacol; 1997 Sep; 335(1):37-42. PubMed ID: 9371544
[TBL] [Abstract][Full Text] [Related]
51. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
Millan MJ; Brocco M; Papp M; Serres F; La Rochelle CD; Sharp T; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2004 Jun; 309(3):936-50. PubMed ID: 14978196
[TBL] [Abstract][Full Text] [Related]
52. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
53. Prominent binding of the dopamine D3 agonist [3H]PD 128907 in the caudate-putamen of the adult rat.
Hillefors M; von Euler M; Hedlund PB; von Euler G
Brain Res; 1999 Mar; 822(1-2):126-31. PubMed ID: 10082890
[TBL] [Abstract][Full Text] [Related]
54. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
55. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
[TBL] [Abstract][Full Text] [Related]
56. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
57. PD128,907 induces ocular hypotension in rabbits: involvement of D2/D3 dopamine receptors and brain natriuretic peptide.
Chu E; Socci R; Chu TC
J Ocul Pharmacol Ther; 2004 Feb; 20(1):15-23. PubMed ID: 15006155
[TBL] [Abstract][Full Text] [Related]
58. In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property.
Cote SR; Kuzhikandathil EV
Neuropharmacology; 2014 Apr; 79():359-67. PubMed ID: 24316466
[TBL] [Abstract][Full Text] [Related]
59. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
Burstein ES; Ma J; Wong S; Gao Y; Pham E; Knapp AE; Nash NR; Olsson R; Davis RE; Hacksell U; Weiner DM; Brann MR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1278-87. PubMed ID: 16135699
[TBL] [Abstract][Full Text] [Related]
60. Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents.
Gyertyán I; Kiss B; Sághy K; Laszy J; Szabó G; Szabados T; Gémesi LI; Pásztor G; Zájer-Balázs M; Kapás M; Csongor EÁ; Domány G; Tihanyi K; Szombathelyi Z
Neurochem Int; 2011 Nov; 59(6):925-35. PubMed ID: 21767587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
